Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF – Get Free Report) is projected to issue its results on Thursday, November 12th. Analysts expect the company to announce earnings of $0.0681 per share and revenue of $26.06 million for the quarter.
Surgical Science Sweden AB (publ) Stock Performance
OTCMKTS SUSRF opened at $5.47 on Wednesday. Surgical Science Sweden AB has a twelve month low of $3.95 and a twelve month high of $5.47. The firm’s 50 day moving average price is $5.29 and its two-hundred day moving average price is $3.96.
Surgical Science Sweden AB (publ) Company Profile
Surgical Science Sweden AB (publ) develops simulation-based training and assessment solutions for medical professionals. Its products use virtual reality and other simulation technologies to help users practise surgical techniques in a controlled environment. The company’s offerings cover areas including laparoscopic, endoscopic and robotic surgery, as well as other clinical skills. Surgical Science serves hospitals, universities and medical-device companies, and works with industry partners to incorporate simulation and training tools into their products and education programs.
Featured Stories
- Five stocks we like better than Surgical Science Sweden AB (publ)
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
